The ACR advocates on behalf of the rheumatology community throughout the year, but it’s always especially exciting when patients join our efforts in Washington, D.C. Close to 100 patients, rheumatologists and representatives of the broader interprofessional team traveled to our nation’s capital this week to participate in the ACR’s annual Advocates for Arthritis event. Participants…
Out of Africa: Pattern, Genetics & Advocacy of Rheumatic Diseases
Rheumatic diseases were once thought of as rare on the African continent. But one session during the 2018 ACR/ARHP Annual Meeting, will dispel this perception—with three speakers presenting on the state of rheumatic disease in Africa…
Celiac Awareness Makes a Difference for Rheumatology Patients
Celiac disease and gluten sensitivity are difficult to diagnose, but they affect multiple systems and are associated with other autoimmune diseases. Lan Chen, MD, PhD, believes better testing and clearer education will be a gamechanger for celiac patients…
California Insurance Commissioner Sues AbbVie over Humira
(Reuters)—On Tuesday, Insurance Commissioner Dave Jones filed a complaint on behalf of the State of California against AbbVie Inc., alleging the drugmaker gave illegal kickbacks to healthcare providers to prescribe its blockbuster drug, Humira. The regulator alleged that AbbVie engaged in a far-reaching scheme including cash, meals, drinks, gifts, trips and patient referrals, as well…
2018 RISE Users Meeting Guides You through MIPS Submission
During the 2018 ACR/ARHP Annual Meeting, the ACR’s Registry Team will hold a RISE user group meeting to showcase the innovative, new RISE dashboard, designed to help maximize your performance scores for MIPS submission. We welcome current RISE users to share their experiences thus far and to be part of the improvement process as we…
Is Concierge Medicine Right for Your Practice?
It is no surprise to practicing physicians that the healthcare landscape is becoming more and more unpredictable. Because of the volatility surrounding today’s healthcare environment, such as increasing overhead costs and decreasing reimbursement rates, many physicians are asking themselves whether there is a different, more lucrative way to practice medicine. Concierge medicine may just be…
Researchers Probe the Role of Fat Cells in Inflammation
AMSTERDAM—It’s been many years since adipose tissue came to be appreciated not just as a store of energy, but also as a regulator of metabolism and an important player in immune function. Rheumatology researchers continue to drill down into the role of fat cells in the search for mechanisms that could reveal targets for the…
Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection
AMSTERDAM—With new therapies coming into the marketplace, researchers are working to tease out the risk of infection for rheumatoid arthritis (RA) patients. Existing data suggest the risk of infections—even fatal ones—is real. But over time, improvements have taken hold, particularly for tuberculosis, according to an infectious disease expert at EULAR: the Annual European Congress of…
Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy
AMSTERDAM—Just how seldom prednisone is successful at inducing remission in giant cell arteritis (GCA), despite such a long history of use for the disease, is one of the many lessons to emerge from the data in the GiACTA trial, said the principal investigator of the trial, which is the largest ever in GCA and is…
Researchers Release Proposed Lupus Criteria, & Pathogenesis Findings
AMSTERDAM—Newly proposed systemic lupus erythematosus (SLE) classification criteria and new findings on SLE pathogenesis are two ways in which researchers and clinicians are getting a better grasp on the heterogeneous disease. The criteria and findings were discussed this June in a session at EULAR: the Annual European Congress of Rheumatology. ‘Paradigm Shift’ Sindhu Johnson, MD,…
- « Previous Page
- 1
- …
- 316
- 317
- 318
- 319
- 320
- …
- 820
- Next Page »